Science Explorer Interactive view Map
Researcher · United States Food and Drug Administration · United States

Laleh Amiri‐Kordestani

Laleh Amiri‐Kordestani publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers and Cancer Treatment and Pharmacology.

ORCID 0000-0002-0056-5437 OpenAlex
World rank
#250,020
of 1,633,909 ranked researchers
Rank in United States
#97,688
of 358,040
Works
24
Citations
114
Citations per work
4.8

What does Laleh Amiri‐Kordestani research?

Oncology: 36.1%Surgery: 30.6%Pulmonary and Respiratory Medicine: 16.7%Economics and Econometrics: 5.6%other fields: 11.0%36%top field
Oncology36.1%Surgery30.6%Pulmonary and Respiratory Medicine16.7%Economics and Econometrics5.6%other fields11.0%

Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.

  1. 1Oncology36% of their works
  2. 2Surgery31% of their works
  3. 3Pulmonary and Respiratory Medicine17% of their works
  4. 4Economics and Econometrics6% of their works
  5. 5Genetics3% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Laleh Amiri‐Kordestani's research?

The keywords of their largest research topics: Chemotherapy, Immunotherapy, Molecular Characterization, Neoadjuvant Therapy, Bladder Cancer, Urothelial Carcinoma, Breast Cancer and Metastatic Breast Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Chemotherapy102 topics
  2. Immunotherapy92 topics
  3. Molecular Characterization92 topics
  4. Neoadjuvant Therapy82 topics
  5. Bladder Cancer71 topic
  6. Urothelial Carcinoma71 topic
  7. Breast Cancer62 topics
  8. Metastatic Breast Cancer62 topics
  9. Immune Checkpoint Blockade51 topic
  10. Metastatic52 topics
  11. PD-1 and PD-L151 topic
  12. CDK4/6 Inhibitors31 topic
  13. Chemotherapy-Induced Peripheral Neuropathy31 topic
  14. HER231 topic
  15. Palbociclib31 topic
  16. Taxanes31 topic
  17. Trastuzumab31 topic
  18. Primary Urethral Carcinoma21 topic
  19. Renal Cell Carcinoma21 topic
  20. Treatment21 topic
  21. Urachal Carcinoma21 topic
  22. Breast Tumours11 topic
  23. Gene Expression11 topic

Where does Laleh Amiri‐Kordestani work?

Laleh Amiri‐Kordestani's main affiliation in the publication record is United States Food and Drug Administration, United States.

How many publications and citations does Laleh Amiri‐Kordestani have?

Science Explorer counts 24 works and 114 citations for Laleh Amiri‐Kordestani, ranking #250,020 of 1,633,909 researchers worldwide on the composite score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.